Therefore, RPS19-targeted HSPCs exhibit selectively impaired erythropoiesis in vitro with intact myelopoiesis, as observed in bone marrow cells from patients with DBA (42, 43). Here, RPS19 is linked to Diamond-Blackfan anemia.